Pfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) of Migraine

Source Summary

TOKYO, July 27, 2026 - (JCN Newswire) - Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative Director: Hiroo Igarashi, "Pfizer") and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo...